Status epilepticus: Lorazepam may be as good as diazepam for stopping seizures
|
|
The study
Double-blinded concealed randomised
trial
without
intention-to-treat
Setting: emergency departments in 3 university hospitals, USA
70 patients
(aged
mean 53,
72%
male)
status epilepticus
- more than three seizures in one hour,
- two seizures or more in rapid succession without regaining consciousness
- partial or complex seizures with confusion, or
- absence seizures with confusion and a characteristic 3 HZ spike
Excluded if
- terminally ill
- cardiac arrhythmia
- hypotensive
- any metabolic disorder (e.g. hypoglycaemic
- history of benzodiazepine sensitivity
- child-bearing potential
- received diazepam already
Control Group: (n = 33, 33 analysed):
diazepam 10 mg over 2 minutes
Experimental Group: (n = 37, 37 analysed):
lorazepam 4 mg over 2 minutes
Patients had a second dose of drug if seizures continued or recurred within 10 minutes. Most had a loading dose of phenytoin
100% followed for
20
minutes
seizures controlled
Outcome notes:
-
seizure controlled after second injection
: 2nd injection was given to only 13 of 14 not responding to first one in placebo group
-
adverse effects
: respiratory depression or arrest/hypotension
The evidence
| Outcome |
Time to outcome |
CER | EER | RRR (95% CI) | ARR (95% CI) | NNT (95% CI) |
| seizures
controlled
after one injection
|
10
minutes |
19 (57.9%) |
29 (78.4%) |
49% (-6% to
75%) |
20.8% (-0.65% to
42.3%) |
5
(NNT = 2 to infinity;
NNH =
153
to infinity)
|
| seizure controlled after second injection
|
20
minutes |
6 (46.2%) |
4 (50%) |
7% (-119% to
61%) |
3.85% (-40.1% to
47.8%) |
26
(NNT = 2 to infinity;
NNH =
2
to infinity)
|
| overall results
|
20
minutes |
25 (75.8%) |
33 (89.1%) |
55% (-35% to
85%) |
13.4% (-4.29% to
31.15%) |
7
(NNT = 3 to infinity;
NNH =
23
to infinity)
|
| adverse effects
|
20
minutes |
5 (15.2%) |
5 (13.5%) |
11% (-35% to
85%) |
13.4% (-4.29% to
31.2%) |
61
(NNT = 6 to infinity;
NNH =
7
to infinity)
|
- not clear if patients were treated similarly by phenytoin loading dose
- none of diazepam patients suffering adverse effects had any concurrent medical problems, while four in lorazepam had clinically important medical problems.
Comments
- Study is too small for definitive benefit.
Citation
-
Leppik
IE,
Derivan
AT,
Homan
RW, et al:
Double-blind study of Lorazepam and diazepam in status epilepticus.
Journal of American Medical Association
1983;
249:
1452-1454
Contributor: Chris Ball and Musab Hayatli,
Unknown Month 2000
Reviewer:
Clinical Question.
| Patient |
status epilepticus |
| Intervention or Exposure |
lorazepam |
| Comparison |
diazepam |
| Outcome |
seizure control, adverse effects |
|
|